Explore the available use cases and the prediction models imported from the Arachne Central platform of the PREPARE Rehab project.
You can inspect each model in detail, including performance metrics, evaluation summaries, and additional analytics.
The developed prediction models are designed to estimate the risk of ischemic or hemorrhagic stroke (and stroke-related death) in hypertensive patients. Specifically, the models were designed to reflect the effects of the four primary drug categories commonly prescribed for hypertension.
The developed prediction models are designed to estimate in individuals with idiopathic scoliosis undergoing different treatments, specific outcomes regarding radiographic progression, quality of life, aesthetics. Specifically, the models were designed to reflect the effects of three treatment options commonly followed for idiopathic scoliosis.
The developed prediction models are designed to estimate in people with thumb base osteoarthritis undergoing non-surgical treatment (i.e splinting, hand therapy, corticosteroid injection) specific outcomes regarding the likelihood of surgical intervention and satisfaction with the treatment results.
The developed prediction models are designed to estimate, in individuals with intermittent claudication undergoing supervised exercise therapy, specific outcomes regarding improvement in walking distance and quality of life.
The developed prediction models are designed to estimate, in patients with spinal disorders undergoing surgical treatment, specific outcomes at 3 months and 1 year after intervention. Primary outcomes include COMI score and pain levels (back/leg pain for back pain patients and neck/arm pain for neck pain patients). Secondary outcomes include patient satisfaction, global treatment outcome, and the occurrence of surgical and general complications.
The developed prediction models are designed to estimate, in patients with Parkinson’s disease or Parkinsonism undergoing intensive rehabilitation or device-related drug/surgical treatments, changes in independence in activities of daily living as measured by UPDRS Part II. Outcomes are evaluated at 3 and 6 months after treatment, with clinical relevance defined by the minimal clinically important difference (MCID) of 3 points.
The models estimate, at discharge, the length of stay and secondary outcomes including place of discharge, walking autonomy, care burden, and use of walking aids in patients undergoing inpatient rehabilitation after hip or knee replacement.
The models estimate, in patients with temporomandibular joint disorders, outcomes of interventions aimed at improving quality of life, reducing pain, enhancing jaw function, and minimizing complications. They support clinical decisions across diagnosis, patient assessment, imaging, pain management, treatment planning, multidisciplinary care, and follow-up.
The models estimate, at admission, outcomes of comprehensive rehabilitation in patients with lower limb loss, including successful prosthesis fitting, prevention of falls, and avoidance of wounds.